Standout Papers

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer 2004 2026 2011 2018 8.3k
  1. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer (2004)
    Herbert I. Hurwitz, Louis Fehrenbacher et al. New England Journal of Medicine
  2. Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer (2005)
    Herbert I. Hurwitz, Louis Fehrenbacher et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 19 from Science/Nature 194 standout
Sub-graph 1 of 13

Citing Papers

Diagnosis and Treatment of Metastatic Colorectal Cancer
2021 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
22 intermediate papers

Works of W. Heim being referenced

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab
2005
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
W. Heim 6507 2954 1264 3280 23 10.0k
Napoleone Ferrara 5592 2387 1158 3572 16 9.4k
Gwen Fyfe 5606 2343 1074 3007 13 8.9k
Robert W. Ross 6050 3472 1536 3883 61 10.9k
Thomas H. Cartwright 7134 2939 1469 3317 81 11.0k
Eric Holmgren 8525 4267 1430 4706 44 13.9k
Mikhail Lichinitser 7634 3765 1288 1651 60 9.7k
Ari David Baron 7460 3340 2272 3479 71 12.6k
Christopher Stroh 5522 2458 1031 1981 76 7.8k
Rafael G. Amado 4917 2258 714 1146 56 6.5k
P. Koralewski 4430 3406 907 2065 58 6.9k

All Works

Loading papers...

Rankless by CCL
2026